Expression of COX-2 proteins in gastric mucosal lesions

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 2

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

247

HTML

1492

Tables (1-3)

216

Sum=1955

Jan 15, 2004 (publication date) through Nov 29, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Reports

World J Gastroenterol. Jan 15, 2004; 10(2): 292-294
Published online Jan 15, 2004. doi: 10.3748/wjg.v10.i2.292

Table 3 COX-2 expression in gastric cancer tissues

Groups	Number	COX-2 n (%)
Type
Intestinal type	24	16 (66.7)
Gastric type	6	4 (66.7)
Stage
Early stage	5	1 (20.0)
Developing	25	19 (76.0)^a
Differentiation (Intestinal type)
High and moderate	14	8 (57.1)
Low and no differentiation	10	8 (80.0)
Lymph node metastasis
Without metastasis	6	1 (16.7)
With metastasis	24	19 (79.2)^a

^aP < 0.05, developing stage vs early stage; metastasis vs no metastasis.

Citation: Yu LZ, Gao HJ, Bai JF, Sun G, Zhao HL, Sun L, Miu K, Zhao ZQ. Expression of COX-2 proteins in gastric mucosal lesions. World J Gastroenterol 2004; 10(2): 292-294
URL: https://www.wjgnet.com/1007-9327/full/v10/i2/292.htm
DOI: https://dx.doi.org/10.3748/wjg.v10.i2.292